BKZ resulted in clinically meaningful improvements in FACIT-Fatigue and pain (PtAAP) in approximately half of pts w/ active PsA who are bDMARD-naïve or TNFi-IR. Abs 2119 #ACR22 @RheumNow https://t.co/29gzmMZRlG https://t.co/qziqGNxQih
Links:
Bimekizumab Treatment Results in Improvements in Fatigue and Pain in Biologic D…
http://ow.ly/EM3q50LAlKT
14-11-2022